cephalosporin c has been researched along with ganciclovir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freifeld, AG | 1 |
| Williams, DN | 1 |
| Aguado, JM; Asensio, A; Blanes, M; Borrell, N; Bou, G; Carratalà, J; Cervera, C; Cisneros, JM; Fortún, J; Gavaldà, J; Gurguí, M; Len, O; Montejo, M; Muñoz, P; Pahissa, A; Rodríguez-Pardo, D; Torre-Cisneros, J | 1 |
1 review(s) available for cephalosporin c and ganciclovir
| Article | Year |
|---|---|
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
2 other study(ies) available for cephalosporin c and ganciclovir
| Article | Year |
|---|---|
Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Ceftriaxone; Cephalosporins; Contraindications; Ganciclovir; HIV; Home Infusion Therapy; Infusions, Intravenous; Insurance, Health, Reimbursement; Patient Education as Topic | 1996 |
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Diarrhea; Female; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Transplants | 2012 |